Synthesis and Biological Activity of Schiff Base Series of Valproyl, N-Valproyl Glycinyl, and N-Valproyl-4-aminobenzoyl Hydrazide Derivatives
-
- El-Faham Ayman
- Department of Chemistry, College of Science, King Saud University Department of Chemistry, Faculty of Science, Alexandria University Institute for Research in Biomedicine-Barcelona
-
- Farooq Muhammad
- Bioproducts Research Chair (BPRC), Department of Zoology, College of Science, King Saud University
-
- Khattab Sherine Nabil
- Department of Chemistry, Faculty of Science, Alexandria University
-
- Elkayal Ahmed Mohamed
- Department of Chemistry, Faculty of Science, Alexandria University
-
- Ibrahim Mahmoud Fawzy
- Department of Chemistry, Faculty of Science, Alexandria University
-
- Abutaha Nael
- Bioproducts Research Chair (BPRC), Department of Zoology, College of Science, King Saud University
-
- Wadaan Mohammad Ahmad
- Bioproducts Research Chair (BPRC), Department of Zoology, College of Science, King Saud University
-
- Hamed Ezzat Awad
- Department of Chemistry, Faculty of Science, Alexandria University Department of Chemistry, Faculty of Science, Beirut Arab University
書誌事項
- タイトル別名
-
- Synthesis and Biological Activity of Schiff Base Series of Valproyl, <i>N</i>-Valproyl Glycinyl, and <i>N</i>-Valproyl-4-aminobenzoyl Hydrazide Derivatives
この論文をさがす
説明
Series of Schiff bases of valproic acid hydrazide, N-valproylglycine hydrazide and N-valproyl-4-aminobenzoyl hydrazide derivatives were synthesized and characterized by IR, NMR (1H- and 13C-NMR) and elemental analysis. The prepared compounds were evaluated in transgenic zebrafish embryos (Tg: flil-1: enhanced green fluorescent protein (EGFP)) for antiangiogenic activity and in HepG2 liver carcinoma cell line for anti cancer activity. The Schiff bases of N-valproylglycine hydrazide derivatives were most potent in term of suppressing angiogenic blood vessels formation and anticancer activity at very low concentration, followed by the Schiff bases of valproic acid hydrazide derivatives which exhibited moderate activity, while the Schiff bases of N-valproyl-4-aminobenzoyl hydrazide derivatives, ethyl 4-(2-propylpentanamido)benzoate (VABE) and N-(4-(hydrazinecarbonyl)phenyl)-2-propylpentanamide (VABH) in contrast exhibited pro-angiogenic activity and weaker anticancer activity which mean that these derivatives targeted a common signaling pathway in term of affecting the blood vessels formation.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 62 (6), 591-599, 2014
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679153371904
-
- NII論文ID
- 130004137262
-
- NII書誌ID
- AA00602100
-
- COI
- 1:STN:280:DC%2BC2cjot1Wluw%3D%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 025478898
-
- PubMed
- 24881666
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可